Cisplatin-Based First-Line Treatment of Elderly Patients With Advanced Non–Small-Cell Lung Cancer: Joint Analysis of MILES-3 and MILES-4 Phase III TrialsCesare Gridelli, Francesco Perrone, Saverio Cinieri et al.|Journal of Clinical Oncology|2018Cited by 70
Weekly docetaxel versus CMF as adjuvant chemotherapy for older women with early breast cancer: final results of the randomized phase III ELDA trialFrancesco Perrone, A. De Matteis, Francesco Nuzzo et al.|Annals of Oncology|2014Cited by 68
Quality of Life Analysis of TORCH, a Randomized Trial Testing First-Line Erlotinib Followed by Second-Line Cisplatin/Gemcitabine Chemotherapy in Advanced Non–Small-Cell Lung CancerMassimo Di Maïo, Cesare Gridelli, Natasha B. Leighl et al.|Journal of Thoracic Oncology|2012Cited by 26
Prognostic impact of education level of patients with advanced non-small cell lung cancer enrolled in clinical trialsMassimo Di Maïo, Cesare Gridelli, Simona Signoriello et al.|Lung Cancer|2012Cited by 22
Risk of failure in dual therapy versus triple therapy in naïve HIV patients: a systematic review and meta-analysisMariantonietta Pisaturo, Nicola Coppola, Lorenzo Onorato et al.|Clinical Microbiology and Infection|2020Cited by 17